Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.415 USD | -4.82% | -1.06% | +35.89% |
05-15 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
05-14 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.89% | 43.85M | |
+52.64% | 63.85B | |
-2.50% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.40% | 26.52B | |
-21.46% | 18.69B | |
+2.79% | 12.73B | |
+22.32% | 12.11B | |
+27.78% | 12.07B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Transcript : Daré Bioscience, Inc., Q3 2022 Earnings Call, Nov 10, 2022